Eli Varon

Dr. Eli Varon

Bar Ilan University, Faculty of Engineering
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Dyes and Pigments
Verified
Journal Article
Closed access
ASAbed Saady
Abed Saady
Eli VaronEli Varon
Eli Varon
AJAvi Jacob
Avi Jacob
YSYaron Shav-Tal
Yaron Shav-Tal
BFBilha Fischer
Bilha Fischer

Verified
Journal Article
Open access
PDF file
Eli VaronEli Varon
Eli Varon
Gaddi BlumrosenGaddi Blumrosen
Gaddi Blumrosen
MSMoshe Sinvani
Moshe Sinvani
EHElina Haimov
Elina Haimov
SPShlomi Polani
Shlomi Polani
OSOrit Shefi
Orit Shefi
Photodynamic therapy (PDT) and photothermal therapy (PTT) are promising therapeutic methods for cancer treatment; however, as single modality therapies, either PDT or PTT is still limited in its success rate. A dual application of both PDT and PTT, in a combined protocol, has gained immense interest. In this study, gold nanoparticles (AuNPs) were conjugated with a PDT agent, meso-tetrahydroxyphenylchlorin (mTHPC) photosensitizer, designed as nanotherapeutic agents that can activate a dual photodynamic/photothermal therapy in SH-SY5Y human neuroblastoma cells. The AuNP-mTHPC complex is biocompatible, soluble, and photostable. PDT efficiency is high because of immediate reactive oxygen species (ROS) production upon mTHPC activation by the 650-nm laser, which decreased mitochondrial membrane potential (∆ψm). Likewise, the AuNP-mTHPC complex is used as a photoabsorbing (PTA) agent for PTT, due to efficient plasmon absorption and excellent photothermal conversion characteristics of AuNPs under laser irradiation at 532 nm. Under the laser irradiation of a PDT/PTT combination, a twofold phototoxicity outcome follows, compared to PDT-only or PTT-only treatment. This indicates that PDT and PTT have synergistic effects together as a combined therapeutic method. Our study aimed at applying the AuNP-mTHPC approach as a potential treatment of cancer in the biomedical field.

1 July 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ASAbed Saady
Abed Saady
VBVerena Böttner
Verena Böttner
MMMelissa Meng
Melissa Meng
Eli VaronEli Varon
Eli Varon
YSYaron Shav-Tal
Yaron Shav-Tal
BFBilha Fischer
Bilha Fischer

1 January 2017 in Biology Methods and Protocols
Verified
Journal Article
Open access
PDF file
JSJonathan Sheinberger
Jonathan Sheinberger
HHHodaya Hochberg
Hodaya Hochberg
ELErez Lavi
Erez Lavi
IKItamar Kanter
Itamar Kanter
SAShira Avivi
Shira Avivi
YSYaron Shav-Tal
Yaron Shav-Tal
Discriminating between the mRNA and protein outputs of each of the alleles of an endogenous gene in intact cells, is a difficult task. To examine endogenous transcripts originating from a specific allele, we applied Central Dogma tagging (CD-tagging), which is based on a tag insertion into an endogenous gene by creation of a new exon. Previously, CD-tagging was used to tag endogenous proteins. Here we developed a CD-tagging-MS2 approach in which two tags were inserted in tandem; a fluorescent protein tag in conjunction with the mRNA MS2 tag used for tagging mRNAs in cells. A cell clone library of CD-tagged-MS2 genes was generated, and protein and mRNA distributions were examined and characterized in single cells. Taking advantage of having one allele tagged, we demonstrate how the transcriptional activity of all alleles, tagged and untagged, can be identified using single molecule RNA fluorescence in situ hybridization (smFISH). Allele-specific mRNA expression and localization were quantified under normal and stress conditions. The latter generate cytoplasmic stress granules (SGs) that can store mRNAs, and the distribution of the mRNAs within and outside of the SGs was measured. Altogether, CD-tagging-MS2 is a robust and inexpensive approach for direct simultaneous detection of an endogenous mRNA and its translated protein product in the same cell.

25 March 2020 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
ASAbed Saady
Abed Saady
MWMelissa Wojtyniak
Melissa Wojtyniak
Eli VaronEli Varon
Eli Varon
VBVerena Boettner
Verena Boettner
NKNoa Kinor
Noa Kinor
BFBilha Fischer
Bilha Fischer

2 November 2026 in ACS Applied Engineering Materials
Verified
Journal Article
Closed access
Eli VaronEli Varon
Eli Varon
OMOz Mualem
Oz Mualem
RGReut Plen Gueta
Reut Plen Gueta
MGMartina Giannaccini
Martina Giannaccini
RVRaffa Vittoria
Raffa Vittoria
OSOrit Shefi
Orit Shefi